Trump Administration Announces New Drug Importation Rules to Reduce Costs
Earlier this week, the Trump Administration issued a 172-page Notice of Proposed Rulemaking (NPRM) that, if finalized, would allow for the importation of certain prescription drugs and biologic products from Canada. The Administration also announced the availability of draft guidance on how manufacturers can import certain FDA-approved products that were originally intended for sale in [...]